123 related articles for article (PubMed ID: 15093601)
1. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
Verma RK; Garg S
Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.
Verma RK; Kaushal AM; Garg S
Int J Pharm; 2003 Sep; 263(1-2):9-24. PubMed ID: 12954176
[TBL] [Abstract][Full Text] [Related]
4. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
Kumar P; Singh S; Mishra B
Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
[TBL] [Abstract][Full Text] [Related]
5. Colon targeted delivery systems of metronidazole based on osmotic technology: development and evaluation.
Kumar P; Singh S; Mishra B
Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1234-42. PubMed ID: 18758093
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.
Philip AK; Pathak K; Shakya P
Eur J Pharm Biopharm; 2008 Jun; 69(2):658-66. PubMed ID: 18206358
[TBL] [Abstract][Full Text] [Related]
7. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
[TBL] [Abstract][Full Text] [Related]
8. Development of a robust once-a-day glipizide matrix system.
Jamzad S; Fassihi R
J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
[TBL] [Abstract][Full Text] [Related]
9. Inlay osmotic pump tablets containing metformin and glipizide.
Patel RB; Patel GN; Patel HR; Patel MM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
Ouyang D; Nie S; Li W; Guo H; Liu H; Pan W
J Pharm Pharmacol; 2005 Jul; 57(7):817-20. PubMed ID: 15969939
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system.
Kumaravelrajan R; Narayanan N; Suba V; Bhaskar K
Int J Pharm; 2010 Oct; 399(1-2):60-70. PubMed ID: 20696225
[TBL] [Abstract][Full Text] [Related]
12. Hot melt granulation: a facile approach for monolithic osmotic release tablets.
Panda RR; Tiwary AK
Drug Dev Ind Pharm; 2012 Apr; 38(4):447-61. PubMed ID: 21954892
[TBL] [Abstract][Full Text] [Related]
13. Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.
Panda RR; Tiwary AK
Ther Deliv; 2010 Dec; 1(6):763-74. PubMed ID: 22834012
[TBL] [Abstract][Full Text] [Related]
14. [Osmotically controlled oral drug delivery systems: an update review].
Wang WP; Xie XQ; Yang DJ; Chen SL
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):598-602. PubMed ID: 18536389
[TBL] [Abstract][Full Text] [Related]
15. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization.
Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C
Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
[TBL] [Abstract][Full Text] [Related]
17. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
Pan H; Jing H; Yang X; Pan W; Chen T
Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
[TBL] [Abstract][Full Text] [Related]
18. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients.
Thombre AG; DeNoto AR; Gibbes DC
J Control Release; 1999 Aug; 60(2-3):333-41. PubMed ID: 10425338
[TBL] [Abstract][Full Text] [Related]
19. Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.
Koennings S; Sapin A; Blunk T; Menei P; Goepferich A
J Control Release; 2007 Jun; 119(2):163-72. PubMed ID: 17428570
[TBL] [Abstract][Full Text] [Related]
20. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
